MRI in Oral Tongue Squamous Cell Carcinoma: A Radiomic Approach in the Local Recurrence Evaluation

Overview

Journal Curr Oncol

Publisher MDPI

Specialty Oncology

Date 2025 Feb 25

PMID 39996916

Authors

Antonello Vidiri

Vincenzo Dolcetti

Francesco Mazzola

Sonia Lucchese

Francesca Laganaro

Francesca Piludu

Raul Pellini

Renato Covello

Simona Marzi

Affiliations

Soon will be listed here.

Abstract

(1) Background: Oral tongue squamous cell carcinoma (OTSCC) is a prevalent malignancy with high loco-regional recurrence. Advanced imaging biomarkers are critical for stratifying patients at a high risk of recurrence. This study aimed to develop MRI-based radiomic models to predict loco-regional recurrence in OTSCC patients undergoing surgery. (2) Methods: We retrospectively selected 92 patients with OTSCC who underwent MRI, followed by surgery and cervical lymphadenectomy. A total of 31 patients suffered from a loco-regional recurrence. Radiomic features were extracted from preoperative post-contrast high-resolution MRI and integrated with clinical and pathological data to develop predictive models, including radiomic-only and combined radiomic-clinical approaches, trained and validated with stratified data splitting. (3) Results: Textural features, such as those derived from the Gray-Level Size-Zone Matrix, Gray-Level Dependence Matrix, and Gray-Level Run-Length Matrix, showed significant associations with recurrence. The radiomic-only model achieved an accuracy of 0.79 (95% confidence interval: 0.69, 0.87) and 0.74 (95% CI: 0.54, 0.89) in the training and validation set, respectively. Combined radiomic and clinical models, incorporating features like the pathological depth of invasion and lymph node status, provided comparable diagnostic performances. (4) Conclusions: MRI-based radiomic models demonstrated the potential for predicting loco-regional recurrence, highlighting their increasingly important role in advancing precision oncology for OTSCC.

References

Burian E, Palla B, Callahan N, Pyka T, Wolff C, von Schacky C . Comparison of CT, MRI, and F-18 FDG PET/CT for initial N-staging of oral squamous cell carcinoma: a cost-effectiveness analysis. Eur J Nucl Med Mol Imaging. 2022; 49(11):3870-3877. PMC: 9399011. DOI: 10.1007/s00259-022-05843-4. View

Fatapour Y, Abiri A, Kuan E, Brody J . Development of a Machine Learning Model to Predict Recurrence of Oral Tongue Squamous Cell Carcinoma. Cancers (Basel). 2023; 15(10). PMC: 10216090. DOI: 10.3390/cancers15102769. View

Fedorov A, Beichel R, Kalpathy-Cramer J, Finet J, Fillion-Robin J, Pujol S . 3D Slicer as an image computing platform for the Quantitative Imaging Network. Magn Reson Imaging. 2012; 30(9):1323-41. PMC: 3466397. DOI: 10.1016/j.mri.2012.05.001. View

Siegel R, Miller K, Fuchs H, Jemal A . Cancer statistics, 2022. CA Cancer J Clin. 2022; 72(1):7-33. DOI: 10.3322/caac.21708. View

Tam S, Amit M, Zafereo M, Bell D, Weber R . Depth of invasion as a predictor of nodal disease and survival in patients with oral tongue squamous cell carcinoma. Head Neck. 2018; 41(1):177-184. DOI: 10.1002/hed.25506. View

Vidiri A, Panfili M, Boellis A, Cristalli G, Gangemi E, Pellini R . The role of MRI-derived depth of invasion in staging oral tongue squamous cell carcinoma: inter-reader and radiological-pathological agreement. Acta Radiol. 2019; 61(3):344-352. DOI: 10.1177/0284185119862946. View

Fortin J, Parker D, Tunc B, Watanabe T, Elliott M, Ruparel K . Harmonization of multi-site diffusion tensor imaging data. Neuroimage. 2017; 161:149-170. PMC: 5736019. DOI: 10.1016/j.neuroimage.2017.08.047. View

Cohen E, Bell R, Bifulco C, Burtness B, Gillison M, Harrington K . The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC). J Immunother Cancer. 2019; 7(1):184. PMC: 6632213. DOI: 10.1186/s40425-019-0662-5. View

Oliver J, Wu S, Chang C, Roden D, Wang B, Hu K . Survival of oral tongue squamous cell carcinoma in young adults. Head Neck. 2019; 41(9):2960-2968. DOI: 10.1002/hed.25772. View

10.

Tagliabue M, Ruju F, Mossinelli C, Gaeta A, Raimondi S, Volpe S . The prognostic role of MRI-based radiomics in tongue carcinoma: a multicentric validation study. Radiol Med. 2024; 129(9):1369-1381. PMC: 11379741. DOI: 10.1007/s11547-024-01859-y. View

11.

Aerts H, Velazquez E, Leijenaar R, Parmar C, Grossmann P, Carvalho S . Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun. 2014; 5:4006. PMC: 4059926. DOI: 10.1038/ncomms5006. View

12.

Mossinelli C, Tagliabue M, Ruju F, Cammarata G, Volpe S, Raimondi S . The role of radiomics in tongue cancer: A new tool for prognosis prediction. Head Neck. 2023; 45(4):849-861. DOI: 10.1002/hed.27299. View

13.

Mannelli G, Comini L, Piazza C . Surgical margins in oral squamous cell cancer: intraoperative evaluation and prognostic impact. Curr Opin Otolaryngol Head Neck Surg. 2019; 27(2):98-103. DOI: 10.1097/MOO.0000000000000516. View

14.

Yuen A, Wei W, Wong Y, Tang K . Elective neck dissection versus observation in the treatment of early oral tongue carcinoma. Head Neck. 1997; 19(7):583-8. DOI: 10.1002/(sici)1097-0347(199710)19:7<583::aid-hed4>3.0.co;2-3. View

15.

Haraguchi K, Yoshiga D, Oda M, Tabe S, Mitsugi S, Takahashi O . Depth of invasion determined by magnetic resonance imaging in tongue cancer can be a predictor of cervical lymph node metastasis. Oral Surg Oral Med Oral Pathol Oral Radiol. 2020; 131(2):231-240. DOI: 10.1016/j.oooo.2020.07.005. View

16.

Zanoni D, Montero P, Migliacci J, Shah J, Wong R, Ganly I . Survival outcomes after treatment of cancer of the oral cavity (1985-2015). Oral Oncol. 2019; 90:115-121. PMC: 6417804. DOI: 10.1016/j.oraloncology.2019.02.001. View

17.

Gillies R, Kinahan P, Hricak H . Radiomics: Images Are More than Pictures, They Are Data. Radiology. 2015; 278(2):563-77. PMC: 4734157. DOI: 10.1148/radiol.2015151169. View

18.

Mali S, Ibrahim A, Woodruff H, Andrearczyk V, Muller H, Primakov S . Making Radiomics More Reproducible across Scanner and Imaging Protocol Variations: A Review of Harmonization Methods. J Pers Med. 2021; 11(9). PMC: 8472571. DOI: 10.3390/jpm11090842. View

19.

Chu C, Lee N, Adeoye J, Thomson P, Choi S . Machine learning and treatment outcome prediction for oral cancer. J Oral Pathol Med. 2020; 49(10):977-985. DOI: 10.1111/jop.13089. View

20.

Faisal M, Dhanani R, Ullah S, Bakar M, Irfan N, Malik K . Correction to: Prognostic outcomes of treatment naïve oral tongue squamous cell carcinoma (OTSCC): a comprehensive analysis of 14 years. Eur Arch Otorhinolaryngol. 2021; 278(8):3055. DOI: 10.1007/s00405-021-06617-8. View